Clinical trial

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer

NCT01500720

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-03-01

PhasePHASE2

Study timeline

Study start (unknown)2012-03-01Date precision: month

Registry last updated2015-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Cancerunresolved

Interventions

CabazitaxelDRUG · verified · RxNorm: cabazitaxel

TopotecanDRUG · verified · RxNorm: topotecan

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

SeoulSouth Korea3 BudapestHungary3 AthensGreece2 ThessalonikiGreece2 Cluj-NapocaRomania2 SantiagoChile2 PhiladelphiaPennsylvania, United States1 BarcelonaSpain1 OmahaNebraska, United States1 MoscowRussia1 WarsawPoland1 Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01500720 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.